Clinical Trial Update: ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ADRCs for hand dysfunction in diffuse systemic sclerosis (scleroderma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma Diffuse
• Systemic Sclerosis Diffuse

Drugs mentioned

• ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma

Snippet

Sponsor: Paracrine, INC. | Conditions: Scleroderma, Diffuse | Phase 3 | Status: UNKNOWN